• 目的研究肝动脉化疗栓塞基础上经皮经门静脉灌注化疗治疗晚期肝癌疗效。

    Objective To study the effect of transcatheter chemoembolization(TACE) plus percutaneous transhepatic portochemotherapy(PTP)for the treatment of primary liver cancer(PLC).

    youdao

  • 结论中晚期不能切除的原发性肝癌使用动脉门静脉双重插管灌注化疗可以改善临床症状延长存活期

    Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.

    youdao

  • 目的探讨动脉门静脉双重插管区域灌注化疗中晚期不能切除原发性肝癌应用方法临床疗效。

    Objective To explore the curative effect of double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma.

    youdao

  • 目的探讨动脉化疗栓塞门静脉持续灌注化疗治疗原发性肝癌临床价值

    Objective To investigate the clinical value about hepatic arterial chemoembolization and portal vein continuous perfusion chemotherapy in the treatment of primary liver cancer.

    youdao

  • 目的探讨动脉化疗栓塞门静脉持续灌注化疗治疗原发性肝癌临床价值

    Objective To investigate the clinical value about hepatic arterial chemoembolization and portal vein continuous perfusion chemotherapy in the treatment of primary liver cancer.

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定